3don MSN
Psilocybin shows greater potential than cannabinoids for obsessive-compulsive disorder treatment
In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids.
Fitgurú on MSN
New study links melatonin to heart failure: Here are 7 safe, natural alternatives for better sleep
A alarming new study suggests the popular sleep aid carries hidden cardiovascular risks. If you are ready to ditch the pills, ...
Learn how CBG may support inflammation, gut health, stress, and sleep in 2026, with a science-informed guide to safe, ...
Nearly half of college students have tried CBD products, according to new research from the University of Georgia.
MedPage Today on MSN
Smartphone-Delivered Digital Therapy Improved Anxiety Symptoms
A randomized trial showed that a smartphone-delivered digital CBT intervention improved generalized anxiety disorder symptoms in adults. The self-paced program uses evidence-based CBT techniques such ...
A science-backed guide to building a smarter CBD and THC wellness routine in 2025, covering sleep, stress, pain, safety, and product quality.
Taste of Home on MSN
Recess drink review: We tried sparkling CBD water to reduce stress
Recess drink is a CBD-infused sparkling water with natural fruit flavors. It claims to not only taste good, but make you feel ...
A Brazilian study investigated the effects of microdoses of cannabis extract in patients with mild Alzheimer’s disease, and found cognitive decline stalled.
Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results